宝利化再获发明专利，为制药行业注入创新活力

Group 1 - Baoli Pharma (Nanjing) Co., Ltd. has successfully obtained a patent for "a preparation and purification device, method, and application of ursodeoxycholic acid," showcasing its strong R&D capabilities and providing new opportunities for the pharmaceutical industry [1] - Ursodeoxycholic acid plays a crucial role in the treatment of various liver and gallbladder diseases, helping to dissolve cholesterol stones and alleviate patient pain [3] - The patented technology significantly enhances the purity and quality stability of ursodeoxycholic acid, offering more reliable and effective treatment options for patients [4] Group 2 - Baoli Pharma has previously achieved success in patenting vitamin B6 injection solutions, marking the latest patent in its innovation journey as a significant milestone [4] - The company emphasizes its commitment to R&D innovation and continuous investment, reflecting its strong technical foundation and innovative capabilities [4] - Baoli Pharma aims to integrate global pharmaceutical technology to safeguard human health, focusing on developing safe and high-quality products and services for the healthcare sector [4]